PLAP-CAR-T cells (ProMab Biotechnologies/Hunan University of Arts and Science/Weatherall Institute of Molecular Medicine)

N/A

Report date: 2025/01/26 17:38:48

Base Information

Drug NamePLAP-CAR-T cells (ProMab Biotechnologies/Hunan University of Arts and Science/Weatherall Institute of Molecular Medicine)
Drug Alias Namehumanized PLAP ScFv-CAR-T cells (ProMab Biotechnologies/Hunan University of Arts and Science/Weatherall Institute of Molecular Medicine)anti-PLAP CAR-T cell therapy (ProMab Biotechnologies/Hunan University of Arts and Science/Weatherall Institute of Molecular Medicine)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAlkaline phosphatase, placental type modulators
TargetsAlkaline phosphatase, placental type
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMRC Weatherall Institute of Molecular Medicine
China Registration ClassN/A

Develop Information

Active CompaniesMRC Weatherall Institute of Molecular MedicineProMab Biotechnologies IncHunan University of Arts and Science
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A